acute myeloid leukemia (aml)

Showing 1 - 25 of 126

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

iN the Real Practice

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Vyxeos liposomal
  • Roma, Italy
    Policlinico Tor Vergata
Nov 16, 2023

Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Vienna, Austria
  • +3 more
Jun 8, 2023

Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Leipzig, Germany
    Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
Apr 25, 2023

Acute Myeloid Leukemia (AML) Trial in United States (Gilteritinib, Ivosidenib, Enasidenib)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Basking Ridge, New Jersey
  • +6 more
Mar 3, 2023

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation Trial in Worldwide

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) Mutation
  • Los Angeles, California
  • +110 more
Jan 26, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Acute Myeloid Leukemia (AML) Trial in Worldwide (Selinexor, Hydroxyurea, Ara-C)

Completed
  • Acute Myeloid Leukemia (AML)
  • Los Angeles, California
  • +77 more
Jan 24, 2023

Acute Myeloid Leukemia (AML), Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Acute Myeloid Leukemia With FMS-like Tyrosine Kinase 3 (FLT3) Mutation / Internal Tandem Duplication (ITD)
  • Cincinnati, Ohio
  • +18 more
Jan 20, 2023

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome Trial in Japan, United States (ASP7517)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome
  • ASP7517
  • Duarte, California
  • +15 more
Jan 19, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Adverse Events and Change in Disease Activity in Participants of

Recruiting
  • Acute Myeloid Leukemia (AML)
    • Anjo-shi, Aichi, Japan
    • +233 more
    Jan 12, 2023

    Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Birmingham, Alabama
    • +2 more
    Jan 3, 2023

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplant (HSCT) Trial in Pittsburgh

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Reduced-Intensity Conditioning Regimen
    • Myeloablative Conditioning Regimen
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Jan 4, 2023

    Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • Nantes, France
      CHU of Nantes
    Dec 16, 2022

    Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

    Active, not recruiting
    • Acute Myeloid Leukemia (AML)
    • High-risk Myelodysplastic Syndrome (MDS)
    • Durham, North Carolina
    • +8 more
    Dec 13, 2022

    Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Guediawaye GOL SUD (Pyronaridine Tetraphosphate)

    Recruiting
    • Acute Myeloid Leukemia (AML)
    • Acute Lymphoblastic Leukemia (ALL)
    • Pyronaridine Tetraphosphate
    • Guediawaye GOL SUD, Dakar, Senegal
      Dalal Jamm Hospital
    Nov 23, 2022

    Adverse Events and Change in Disease Activity in Participants

    Recruiting
    • Acute Myeloid Leukemia (AML)
      • Seoul, Seoul Teugbyeolsi, Korea, Republic of
      • +5 more
      Nov 4, 2022

      Acute Myeloid Leukemia (AML) Trial in United States (Alvocidib (flavopiridol) and cytarabine (Ara-C), Alvocidib (flavopiridol))

      Terminated
      • Acute Myeloid Leukemia (AML)
      • Alvocidib (flavopiridol) and cytarabine (Ara-C)
      • Alvocidib (flavopiridol)
      • Clovis, California
      • +17 more
      Sep 22, 2022

      Acute Myeloid Leukemia (AML) Trial in Austria, Germany (Dasatinib, Cytarabine, Daunorubicin)

      Active, not recruiting
      • Acute Myeloid Leukemia (AML)
      • Innsbruck, Austria
      • +53 more
      Sep 19, 2022

      Acute Myeloid Leukemia (AML) Trial in Worldwide (standard combination chemo, decitabine)

      Active, not recruiting
      • Acute Myeloid Leukemia (AML)
      • Edegem, Antwerpen, Belgium
      • +52 more
      Sep 13, 2022

      Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • +2 more
      • Personalized rATG (P-rATG)
      • +7 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Aug 31, 2022

      Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Cancer
      • Scottsdale, Arizona
      • +169 more
      Aug 23, 2022

      Acute Myeloid Leukemia (AML), B-cell Non-Hodgkin's Lymphoma (B-NHL), Multiple Myeloma (MM) Trial in Shanghai (Autologous CAR-T

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • +4 more
      • Autologous CAR-T cells
      • +2 more
      • Shanghai, Shanghai, China
        Shanghai Pudong Hospital, Fudan University Affiliated Pudong Med
      Aug 22, 2022

      Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Worldwide (Lemzoparlimab, Azacitidine, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndrome (MDS)
      • Birmingham, Alabama
      • +35 more
      Aug 19, 2022

      Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

      Recruiting
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndromes (MDS)
      • Beijing, Beijing, China
      • +13 more
      Aug 16, 2022